Economic impact of self-administered subcutaneous versus clinic-administered intravenous immunoglobulin G therapy in Alberta, Canada: a population-based cohort study.

Ritchie, Bruce; Martins, Karen J B; Tran, Dat T; Blain, Heather; Richer, Lawrence; Klarenbach, Scott W

Ritchie, Bruce; Martins, Karen J B; Tran, Dat T; Blain, Heather; Richer, Lawrence; Klarenbach, Scott W.

Afiliación

Ritchie B; Department of Medicine, University of Alberta, Edmonton, Canada.
Martins KJB; Real World Evidence Unit, University of Alberta, Edmonton, AB, Canada.
Tran DT; Institute of Health Economics, Edmonton, AB, Canada.
Blain H; School of Public Health, University of Alberta, Edmonton, AB, Canada.
Richer L; Alberta Precision Laboratories, Edmonton, AB, Canada.
Klarenbach SW; Department of Pediatrics, University of Alberta, Edmonton, AB, Canada.

Allergy Asthma Clin Immunol ; 18(1): 99, 2022 Nov 24.

Article en En | MEDLINE | ID: mdl-36434668

Palabras clave

Administrative data; Clinic-based administration; Home-based administration; Immunoglobulin G; Intravenous; Real world evidence; Subcutaneous

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Guideline / Health_economic_evaluation / Observational_studies Idioma: En Revista: Allergy Asthma Clin Immunol Año: 2022 Tipo del documento: Article País de afiliación: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google